CV Sciences (CVSI) EBT (2011 - 2026)

CV Sciences (CVSI) reported EBT of -$643000.0 for Q1 2026, down 530.39% on a YoY basis from $149398.6 in Q1 2025, and down 494.48% sequentially from $163000.0 in Q4 2025.

CV Sciences (CVSI) EBT (2011 - 2026) Analysis & Trends

CV Sciences (CVSI) has 16 years of EBT data on file, last reported at -$643000.0 in Q1 2026.

  • For the quarter ending Q1 2026, EBT fell 530.39% year-over-year to -$643000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 30.72% YoY), and the FY2025 full-year result was -$582000.0, up 72.82% from the prior year.
  • EBT eased to -$643000.0 in Q1 2026, from $163000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $5.7 million in Q1 2023 to a low of -$2.7 million in Q2 2022.
  • A 5-year average of -$495823.5 and a median of -$584000.0 in 2024 frame the typical range for EBT.
  • Across the five-year window, EBT sank 2477.5% in 2022 and jumped 369.79% in 2023, its largest moves.
  • Tracing CVSI's EBT over 5 years: stood at -$2.4 million in 2022, then jumped by 62.83% to -$878000.0 in 2023, then soared by 45.44% to -$479000.0 in 2024, then jumped by 134.03% to $163000.0 in 2025, then sank by 494.48% to -$643000.0 in 2026.
  • Business Quant data shows CVSI's EBT at -$643000.0 in Q1 2026, $163000.0 in Q4 2025, and -$382000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 437.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 758.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.90 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 318.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -247.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 246.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 87.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn -643,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -643,000.00
Dec 31, 2025 163,000.00
Sep 30, 2025 -382,000.00
Jun 30, 2025 -261,000.00
Mar 31, 2025 -102,000.00
Dec 31, 2024 -479,000.00
Sep 30, 2024 -456,000.00
Jun 30, 2024 -584,000.00
Mar 31, 2024 -622,000.00
Dec 31, 2023 -878,000.00
Sep 30, 2023 -447,000.00
Jun 30, 2023 -1.29 Mn
Mar 31, 2023 5.71 Mn
Dec 31, 2022 -2.36 Mn
Sep 30, 2022 -1.03 Mn
Jun 30, 2022 -2.65 Mn
Mar 31, 2022 -2.12 Mn
Dec 31, 2021 -8.96 Mn
Sep 30, 2021 -40,000.00
Jun 30, 2021 -3.52 Mn